SCHEMBL5678342

SCHEMBL5678342

CCCCc1c(C)c(CC)cc(OC(=O)O)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.39
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
PPARD Q03181 1/20 0.38
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
HCAR3 P49019 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
FFAR1 O14842 1/20 0.34
ESR1 P03372 1/20 0.34
PTGS2 P35354 3/20 0.33
SMPD3 Q9NY59 1/20 0.33
LTB4R Q15722 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678309 0.96 ALOX5 (0.44) ALOX5PPARGPPARAPPARDPTGS2
SCHEMBL5680701 0.94 PPARG (0.40) ALOX5PPARGPPARAPPARDNPC1
SCHEMBL5678607 0.93 ALOX5 (0.38) ALOX5PPARGPPARAPPARDNPC1
SCHEMBL5920075 0.93 LDHA (0.39) ALOX5PPARGPPARAPPARDLTB4R
SCHEMBL5920563 0.90 ALOX5 (0.40) ALOX5PPARGPPARAPPARDNPC1
SCHEMBL5920219 0.89 ALOX5 (0.43) ALOX5PPARGPPARAPPARDPTGS2
SCHEMBL5677643 0.89 PPARG (0.44) ALOX5PPARGPPARAPPARDPTGS2
SCHEMBL5680669 0.88 PPARG (0.38) ALOX5PPARGPPARAPPARDNPC1
SCHEMBL5588184 0.88 ALOX5 (0.39) ALOX5PPARGPPARAPPARDNPC1
SCHEMBL5678455 0.87 PPARG (0.43) ALOX5PPARGPPARAPPARDPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR ALOX5 833/4885PPARG 3732/4885PPARA 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.